Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research
Review Expression, function and clinical relevance of MIA (Melanoma Inhibitory Activity)
Upregulation of the splice variant MUC4/Y in the pancreatic cancer cell line MIA PaCa-2 potentiates proliferation and suppresses apoptosis: New insight into the presence of the transcript variant of MUC4
PDF) Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells
IJMS | Free Full-Text | Differentially Expressed microRNAs in MIA PaCa-2 and PANC-1 Pancreas Ductal Adenocarcinoma Cell Lines are Involved in Cancer Stem Cell Regulation | HTML
NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology in: Journal of the National Comprehensive Cancer Network Volume 9 Issue Suppl_5 (2011)
MIA PaCa-2 pancreatic xenograft tumor model - Hera BioLabs
Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients - ScienceDirect
Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research
MIA PaCa-2 tumors lack tonal mature vasculature. Hs766t, MIA PaCa-2 and... | Download Scientific Diagram
Small Molecules Antagonise the MIA-Fibronectin Interaction in Malignant Melanoma | Scientific Reports
Tumormarker beim malignen Melanom
Ganglioside GM2, highly expressed in the MIA PaCa-2 pancreatic ductal adenocarcinoma cell line, is correlated with growth, invasion, and advanced stage | Scientific Reports
Relevance of MIA and S100 serum tumor markers to monitor BRAF inhibitor therapy in metastatic melanoma patients - ScienceDirect
Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells | Cancer Cell International | Full Text
Frontiers | Increased Tumor Intrinsic Growth Potential and Decreased Immune Function Orchestrate the Progression of Lung Adenocarcinoma
Pancreatic Cancer Tumor Markers | GeneTex
Melanoma Inhibitory Activity (MIA) increases the invasiveness of pancreatic cancer cells | Cancer Cell International | Full Text
Evaluation of a Gene-Directed Enzyme-Product Therapy (GDEPT) in Human Pancreatic Tumor Cells and Their Use as In Vivo Models for Pancreatic Cancer | PLOS ONE
Role of Biomarkers in the Integrated Management of Melanoma
Detection of circulating tumor cells in blood of pancreatic ductal adenocarcinoma patients
Targeting Melanoma Metastasis and Immunosuppression with a New Mode of Melanoma Inhibitory Activity (MIA) Protein Inhibition | PLOS ONE
![Figure, Figure showing Tumour, Node, Metastasis...] - StatPearls - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK563159/bin/Staging.jpg "Figure, Figure showing Tumour, Node, Metastasis...] - StatPearls - NCBI Bookshelf")
Figure, Figure showing Tumour, Node, Metastasis...] - StatPearls - NCBI Bookshelf
Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells | Anticancer Research
Flow cytometry analysis of morphology and stem cell marker expression... | Download Scientific Diagram
![PDF] Expression, function and clinical relevance of MIA (melanoma inhibitory activity). | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/36a19fd1832a1c9331c4960d22f4bbd6196d9c32/2-Figure2-1.png "PDF] Expression, function and clinical relevance of MIA (melanoma inhibitory activity). | Semantic Scholar")
PDF] Expression, function and clinical relevance of MIA (melanoma inhibitory activity). | Semantic Scholar
Tumormarker beim malignen Melanom
